1-3 of 3
Jayne Leggo
Close
Sort by
Journal Articles

Clearance and Genetic Variability of Von Willebrand Factor Are Major Determinants of the Pharmacokinetic Behavior of Factor VIII Concentrates in the Treatment of Pediatric Hemophilia A

Kenichi Ogiwara, MD PhD, Laura L Swystun, PhD, Ilinca Georgescu, Christine Brown, Angie Tuttle, Shawn Tinlin, Jayne Leggo, Silvia Albánez, MSc, Manuel Carcao, MD MSc, Victor S. Blanchette, MD FRCPC, Christoph Male, MD MSC, Katharina Thom, David Lillicrap, MD
Journal: Blood
Blood (2014) 124 (21): 473.
https://doi.org/10.1182/blood.V124.21.473.473
Published: 2014
Journal Articles

The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study

Paula D. James, Colleen Notley, Carol Hegadorn, Jayne Leggo, Angie Tuttle, Shawn Tinlin, Christine Brown, Chandler Andrews, Andrea Labelle, Yvette Chirinian, Lee O'Brien, Maha Othman, Georges Rivard, Dilys Rapson, Christine Hough, David Lillicrap, for the Association of Hemophilia Clinic Directors of Canada
Journal: Blood
Blood (2006) 109 (1): 145–154.
https://doi.org/10.1182/blood-2006-05-021105
Published: 2006
Journal Articles

Aminoglycoside suppression of nonsense mutations in severe hemophilia

Clinical Trials & Observations
Paula D. James, Sanj Raut, Georges E. Rivard, Man-Chiu Poon, Margaret Warner, Susan McKenna, Jayne Leggo, David Lillicrap
Journal: Blood
Blood (2005) 106 (9): 3043–3048.
https://doi.org/10.1182/blood-2005-03-1307
Published: 2005